Jennifer Young Joins icometrix As CEO

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

icometrix offers software solutions for extracting clinically meaningful data from brain scans using artificial intelligence (AI), is proud to announce that Jennifer Young has joined as Chief Commercial Officer.

Having served in commercial leadership and executive roles in three Fortune 500 companies, Jennifer brings over 20 years of experience in the radiology, medical device, and healthcare services business spanning the provider, employer and payer markets.

Jennifer will be responsible for building the commercial strategy and expanding the commercial organization to accelerate icometrix‘s growth strategy.

Jennifer earned an MBA at Caldwell University and is a graduate of the Jack F. Welch Global Leadership Development Program in Crotonville, NY. Jennifer’s passion to improve patient care and outcomes, while helping healthcare systems work better for their patients, brought her to icometrix.

“I’m excited and honored to join the icometrix team,” says Jennifer. “I have always had an affinity for radiology and the value it delivers to patients, clinicians, and research. icometrix is shaping the future of radiology and is dedicated to improving patient care and outcomes, both through the referring physicians it serves, as well as through the pharmaceutical industry. We have an opportunity to bring together various clinical stakeholders to improve the quality of life for patients with neurological conditions such as multiple sclerosis, dementia, and brain trauma.”

“We are thrilled that Jennifer Young joined our amazing team as CCO,” says Wim Van Hecke, CEO of icometrix. “Her combined expertise in radiology, the pharmaceutical industry, and the payer market is extremely unique. I look forward to working closely with Jennifer to help radiologists, hospitals, pharmaceutical companies, and above all, patients,” Wim Van Hecke concludes.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.